Skip to content

Clinical trials

Phase 3 Ischemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemia Phase: Phase 3 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20041
20051
20061
20071
20081
20092

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acusphere2
Abiomed Inc.1
Astellas Pharma Inc1
AstraZeneca1
CoAxia1
Gilead Sciences1
Johns Hopkins University1
Medicure1
Spectros Corporation1
The Camelot Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemia11
Coronary Artery Disease5
Heart Diseases5
Myocardial Ischemia4
Arterial Occlusive Diseases2
Arteriosclerosis2
Stroke2
Vascular Diseases2
Acute Coronary Syndrome1
Angina Pectoris1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.